France Says It’s Developing Bionic Supersoldiers Because “Everyone Else Is Doing It”

A report published last Tuesday by the French Military Ethics Committee has indicated that the country has begun to develop technology for bionically enhanced soldiers. The report discussed conditions in which devices like implants can be used to improve soldier performance on the battlefield.

“Human beings have long sought ways to increase their physical or cognitive abilities in order to fight wars. Possible advances could ultimately lead to capacity enhancements being introduced into soldiers’ bodies,” the report said, according to the BBC.

The report said that maintaining clear ethical lines would be important in the development of bionic soldiers. The report called for eugenic or genetic applications of the technology to be banned, as well as anything “that could jeopardise the soldier’s integration into society or return to civilian life”.

The country’s military leaders believe that it is necessary to develop this technology because not doing so would allow other countries to get ahead and gain a military advantage.

In a speech last week, Defence Minister Florence Parly, said that the country’s military doesn’t plan on developing anything extremely “invasive” right away, but said that this could be an option in the future because other countries will be pushing the technology as far as they can.

We must face the facts. Not everyone shares our scruples and we must be prepared for whatever the future holds,” Parly said.

Parly went on to promise that the French government would seek to find a balance, and will find “ways to maintain our operational superiority without turning our backs on our values.”

Parly also pointed out that similar technologies, such as neural implants, have already been introduced to civilian fields without much controversy.

Keep reading

Goldman Sachs asks in biotech research report: ‘Is curing patients a sustainable business model?’

Goldman Sachs analysts attempted to address a touchy subject for biotech companies, especially those involved in the pioneering “gene therapy” treatment: cures could be bad for business in the long run.

“Is curing patients a sustainable business model?” analysts ask in an April 10 report entitled “The Genome Revolution.”

“The potential to deliver ‘one shot cures’ is one of the most attractive aspects of gene therapy, genetically-engineered cell therapy and gene editing. However, such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies,” analyst Salveen Richter wrote in the note to clients Tuesday. “While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow.”WATCH NOWVIDEO01:37Biotech shares soar on dealmaking, drug progress

Richter cited Gilead Sciences’ treatments for hepatitis C, which achieved cure rates of more than 90 percent. The company’s U.S. sales for these hepatitis C treatments peaked at $12.5 billion in 2015, but have been falling ever since. Goldman estimates the U.S. sales for these treatments will be less than $4 billion this year, according to a table in the report.

“GILD is a case in point, where the success of its hepatitis C franchise has gradually exhausted the available pool of treatable patients,” the analyst wrote. “In the case of infectious diseases such as hepatitis C, curing existing patients also decreases the number of carriers able to transmit the virus to new patients, thus the incident pool also declines … Where an incident pool remains stable (eg, in cancer) the potential for a cure poses less risk to the sustainability of a franchise.”

The analyst didn’t immediately respond to a request for comment.

Keep reading

Big Brother in Disguise: The Rise of a New, Technological World Order

“You had to live—did live, from habit that became instinct—in the assumption that every sound you made was overheard, and, except in darkness, every movement scrutinized.”—George Orwell, 1984

It had the potential for disaster.

Early in the morning of Monday, December 15, 2020, Google suffered a major worldwide outage in which all of its internet-connected services crashed, including Nest, Google Calendar, Gmail, Docs, Hangouts, Maps, Meet and YouTube.

The outage only lasted an hour, but it was a chilling reminder of how reliant the world has become on internet-connected technologies to do everything from unlocking doors and turning up the heat to accessing work files, sending emails and making phone calls.

A year earlier, a Google outage resulted in Nest users being unable to access their Nest thermostats, Nest smart locks, and Nest cameras. As Fast Company reports, “This essentially meant that because of a cloud storage outage, people were prevented from getting inside their homes, using their AC, and monitoring their babies.”

Welcome to the Matrix.

Keep reading

Emails Reveal Scientific Effort To Engineer ‘Natural Origin’ Theory, Dispel ‘Fringe’ Lab Speculation For COVID-19

Newly obtained emails offer glimpses into how a narrative of certainty developed about the natural origins of the novel coronavirus SARS-CoV-2, while key scientific questions remained. The internal discussions and an early draft of a scientists’ letter show experts discussing gaps in knowledge and unanswered questions about lab origin, even as some sought to tamp down on “fringe” theories about the possibility the virus came from a lab.

Influential scientists and many news outlets have described the evidence as “overwhelming” that the virus originated in wildlife, not from a lab. However, a year after the first reported cases of SARS-CoV-2 in the Chinese city of Wuhan, little is known how or where the virus originated. Understanding the origins of SARS-CoV-2, which causes the disease COVID-19, may be crucial to preventing the next pandemic.

The emails of coronavirus expert Professor Ralph Baric – obtained through a public records request by U.S. Right to Know – show conversations between National Academy of Sciences (NAS) representatives, and experts in biosecurity and infectious diseases from U.S. universities and the EcoHealth Alliance.

On Feb. 3, the White House Office of Science and Technology Policy (OSTP) asked the National Academies of Sciences, Engineering and Medicine (NASEM) to “convene meeting of experts… to assess what data, information and samples are needed to address the unknowns, in order to understand the evolutionary origins of 2019-nCoV, and more effectively respond to both the outbreak and any resulting misinformation.”

Keep reading

U-2 Spy Plane Taps Into Computers On The Ground To Expand Data Processing Ability Mid-Mission

Lockheed Martin’s Skunk Works advanced projects division recently demonstrated the ability of a U-2S Dragon Lady spy plane to remotely use computers on the ground to help process data from onboard sensors and other systems in flight. The U-2S did this by leveraging a system that Skunk Works and the U.S. Air Force recently used to show how these aircraft, as well as others, will be able to receive updates for their mission computers, including new code to add previously unavailable functionality, in mid-air in the future.

This “distributed processing” flight test took place in November, according to Skunk Works. The U-2S involved was able to establish a link to “a ground node” via a computer cloud, through which it was able to better disseminate sensor information. Doing this allowed the aircraft to make use of additional computer processing power offboard the aircraft.

Keep reading